Follow
Kara M. Ruicci
Kara M. Ruicci
MD PhD, Radiation Oncology, University of Toronto
Verified email at uwo.ca
Title
Cited by
Cited by
Year
ERK-TSC2 signalling in constitutively-active HRAS mutant HNSCC cells promotes resistance to PI3K inhibition
KM Ruicci, N Pinto, MI Khan, J Yoo, K Fung, D MacNeil, JS Mymryk, ...
Oral Oncology 84, 95-103, 2018
372018
Repurposing Albendazole: new potential as a chemotherapeutic agent with preferential activity against HPV-negative head and neck squamous cell cancer
F Ghasemi, M Black, F Vizeacoumar, N Pinto, KM Ruicci, CCSH Le, ...
Oncotarget 8 (42), 71512, 2017
342017
Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
KM Ruicci, P Plantinga, N Pinto, MI Khan, W Stecho, SS Dhaliwal, J Yoo, ...
Molecular Oncology, 2019
302019
Mutational analysis of head and neck squamous cell carcinoma stratified by smoking status
F Ghasemi, SD Prokopec, D MacNeil, N Mundi, SF Gameiro, C Howlett, ...
JCI Insight 4 (1), 2019
272019
A controlled trial of HNSCC patient‐derived xenografts reveals broad efficacy of PI3Kα inhibition in controlling tumor growth
KM Ruicci, J Meens, RX Sun, G Rizzo, N Pinto, J Yoo, K Fung, D MacNeil, ...
International journal of cancer 145 (8), 2100-2106, 2019
242019
Lestaurtinib is a potent inhibitor of anaplastic thyroid cancer cell line models
N Pinto, SD Prokopec, F Vizeacoumar, K Searle, M Lowerison, KM Ruicci, ...
PloS one 13 (11), e0207152, 2018
202018
Genomic and human papillomavirus profiling of an oral cancer cohort identifies TP53 as a predictor of overall survival
N Mundi, SD Prokopec, F Ghasemi, A Warner, K Patel, D MacNeil, ...
Cancers of the head & neck 4, 1-8, 2019
142019
High-throughput testing in head and neck squamous cell carcinoma identifies agents with preferential activity in human papillomavirus-positive or negative cell lines
F Ghasemi, M Black, RX Sun, F Vizeacoumar, N Pinto, KM Ruicci, J Yoo, ...
Oncotarget 9 (40), 26064, 2018
142018
TAM family receptors in conjunction with MAPK signalling are involved in acquired resistance to PI3Kα inhibition in head and neck squamous cell carcinoma
KM Ruicci, J Meens, P Plantinga, W Stecho, N Pinto, J Yoo, K Fung, ...
Journal of Experimental & Clinical Cancer Research 39, 1-18, 2020
132020
Flavopiridol causes cell cycle inhibition and demonstrates anti-cancer activity in anaplastic thyroid cancer models
N Pinto, SD Prokopec, F Ghasemi, J Meens, KM Ruicci, IM Khan, N Mundi, ...
PloS one 15 (9), e0239315, 2020
132020
Introduction and expression of PIK3CAE545K in a papillary thyroid cancer BRAFV600E cell line leads to a dedifferentiated aggressive phenotype
N Pinto, KM Ruicci, MI Khan, MH Shaikh, YFP Zeng, J Yoo, K Fung, ...
Journal of Otolaryngology-Head & Neck Surgery 51 (1), 7, 2022
82022
Spleen tyrosine kinase expression is correlated with human papillomavirus in head and neck cancer
M Black, F Ghasemi, RX Sun, W Stecho, A Datti, J Meens, N Pinto, ...
Oral Oncology 101, 104529, 2020
72020
Erratum to: Disruption of the RICTOR/mTORC2 complex enhances the response of head and neck squamous cell carcinoma cells to PI3K inhibition
KM Ruicci, P Plantinga, N Pinto, MI Khan, W Stecho, SS Dhaliwal, J Yoo, ...
Molecular Oncology 14 (1), 230, 2020
22020
Aesthetic Reconstruction of the Gauge Earlobe: Surgical Technique and Case Series.
KM Ruicci, CC Moore
Facial Plastic Surgery & Aesthetic Medicine 24 (4), 332-333, 2021
12021
JAK2 as a novel therapeutic target in anaplastic thyroid cancer
NC Pinto, K Ruicci, S Prokopec, K Searle, M Lowerison, J Yoo, K Fung, ...
Cancer Research 77 (13_Supplement), 2137-2137, 2017
12017
The genomic and evolutionary landscapes of anaplastic thyroid carcinoma
PYF Zeng, SD Prokopec, SY Lai, N Pinto, MA Chan-Seng-Yue, ...
Cell Reports 43 (3), 2024
2024
The genomic, evolutionary and functional landscapes of anaplastic thyroid carcinoma
PYF Zeng, SD Prokopec, SY Lai, N Pinto, MA Chan-Seng-Yue, ...
medRxiv, 2023.04. 10.23288365, 2023
2023
Mucosal melanoma of the oral cavity
KM Ruicci, M Wunder
University of Western Ontario Medical Journal 89 (1), 2021
2021
Abstract IA02: Utilizing patient-derived xenografts for prognostication and biomarker discovery
C Karamboulas, JP Bruce, KM Ruicci, W Xu, AC Nichols, L Ailles
Clinical Cancer Research 26 (12_Supplement_2), IA02-IA02, 2020
2020
Utilizing patient-derived xenografts for prognostication and biomarker discovery
C Karamboulas, JP Bruce, KM Ruicci, W Xu, AC Nichols, L Ailles
CLINICAL CANCER RESEARCH 26 (12), 15-15, 2020
2020
The system can't perform the operation now. Try again later.
Articles 1–20